Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 531

    1.

    FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group.

    Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K; Diabetes Research in Children Network (DirecNet) Study Group.

    Diabetes Care. 2008 Mar;31(3):525-7. Epub 2007 Dec 20. No abstract available. PMID: 18096811 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.

    Diabetes Research in Children Network Study Group, Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K.

    Pediatr Diabetes. 2009 Apr;10(2):91-6. Epub 2008 Oct 20.PMID: 19175899 [PubMed - indexed for MEDLINE]Related articles

    3.

    Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.

    Deiss D, Kordonouri O, Hartmann R, Hopfenmüller W, Lüpke K, Danne T.

    Pediatr Diabetes. 2007 Jun;8(3):157-62.PMID: 17550426 [PubMed - indexed for MEDLINE]Related articles

    4.

    Educating families on real time continuous glucose monitoring: the DirecNet navigator pilot study experience.

    Messer L, Ruedy K, Xing D, Coffey J, Englert K, Caswell K, Ives B.

    Diabetes Educ. 2009 Jan-Feb;35(1):124-35.PMID: 19244568 [PubMed - indexed for MEDLINE]Related articles

    6.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Continuous glucose monitoring in children with type 1 diabetes.

    Diabetes Research in Children Network (DirecNet) Study Group, Buckingham B, Beck RW, Tamborlane WV, Xing D, Kollman C, Fiallo-Scharer R, Mauras N, Ruedy KJ, Tansey M, Weinzimer SA, Wysocki T.

    J Pediatr. 2007 Oct;151(4):388-93, 393.e1-2. Epub 2007 Aug 24.PMID: 17889075 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus.

    Liberatore R Jr, Perlman K, Buccino J, Artiles-Sisk A, Daneman D.

    J Pediatr Endocrinol Metab. 2004 Feb;17(2):223-6.PMID: 15055358 [PubMed - indexed for MEDLINE]Related articles

    10.

    Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy.

    Albright ES, Desmond R, Bell DS.

    Diabetes Care. 2004 Feb;27(2):632-3. No abstract available. PMID: 14747268 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Studies show Lantus to be effective, safe and flexible in the treatment of type 1 diabetes.

    Walczak IM.

    Diabetes Technol Ther. 2002;4(5):744-5. No abstract available. PMID: 12458569 [PubMed - indexed for MEDLINE]Related articles

    13.

    A randomized cross-over trial to identify the optimal use of insulin glargine in prepubertal children using a three-times daily insulin regimen.

    Fröhlich-Reiterer EE, Ong KK, Regan F, Salzano G, Acerini CL, Dunger DB.

    Diabet Med. 2007 Dec;24(12):1406-11.PMID: 18042082 [PubMed - indexed for MEDLINE]Related articles

    14.

    A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.

    Hassan K, Rodriguez LM, Johnson SE, Tadlock S, Heptulla RA.

    Pediatrics. 2008 Mar;121(3):e466-72. Epub 2008 Feb 25.PMID: 18299307 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Updating the insulin lispro file.

    Grossman LD.

    CMAJ. 1998 May 5;158(9):1132-3. No abstract available. PMID: 9597962 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes.

    Diabetes Research in Children Network (DirecNet) Study Group.

    Pediatr Diabetes. 2006 Feb;7(1):32-8.PMID: 16489972 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software.

    Garg SK, Bookout TR, McFann KK, Kelly WC, Beatson C, Ellis SL, Gutin RS, Gottlieb PA.

    Diabetes Technol Ther. 2008 Oct;10(5):369-75.PMID: 18715213 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of mixing glargine and short-acting insulin analogs on glucose control.

    Kaplan W, Rodriguez LM, Smith OE, Haymond MW, Heptulla RA.

    Diabetes Care. 2004 Nov;27(11):2739-40. No abstract available. PMID: 15505016 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The rate of improvement in metabolic control in children with diabetes mellitus type 1 on insulin glargine depends on age.

    Deja G, Jarosz-Chobot P, Polanska J.

    Exp Clin Endocrinol Diabetes. 2007 Nov;115(10):662-8.PMID: 18058601 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes.

    Guevara-Aguirre J, Guevara-Aguirre M, Saavedra J, Bernstein G, Rosenbloom AL.

    Diabetes Technol Ther. 2007 Aug;9(4):372-6.PMID: 17705693 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data